Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks
Full-thickness Rotator Cuff Tear
About this trial
This is an interventional treatment trial for Full-thickness Rotator Cuff Tear
Eligibility Criteria
Inclusion Criteria:
- Patients will be eligible for inclusion in the study if they have a full-thickness rotator cuff tear that has been deemed reparable by preoperative MRI. They will be included in the study if they are medically stable to undergo the surgery and consent to involvement in the study.
Exclusion Criteria:
- Prior surgery on the involved shoulder
- Preoperative MRI suggesting that the rotator cuff tear is irreparable
- Patients with known allergies to oxycodone, ropivacaine or a similar drug
- Workman's compensation patients
- Patients who do not fill out their visual analog scores or their medication diaries
- Patients with labral or subscapularis tears requiring repair
Sites / Locations
- Orlando Orthopaedic Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Ropivacaine infusion
Saline infusion
270cc of Ropivacaine infusion at 5cc per hour. All patients will receive a reservoir for their catheters containing 280cc of either ropivacaine or saline that will infuse at a rate of 6cc per hour. The reservoirs will be attached in the operating room at the completion of the rotator cuff repair. Patients will be randomized intraoperative to receive either the ropivacaine or the saline.
270cc of Normal Saline infusion at 5cc per hour. All patients will receive a reservoir for their catheters containing 280cc of either ropivacaine or saline that will infuse at a rate of 6cc per hour. The reservoirs will be attached in the operating room at the completion of the rotator cuff repair. Patients will be randomized intraoperative to receive either the ropivacaine or the saline.